| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/20/2005 | EP1259629B1 Recombinant influenza a viruses |
| 07/20/2005 | EP1253823A4 Controlling offspring's sex ratio by targeting transgenes onto the sex chromosomes |
| 07/20/2005 | EP1241254B1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 07/20/2005 | EP1229965B1 Placental human neurokinin b precursor |
| 07/20/2005 | EP1228246B1 Method for distinguishing 5-position methylation changes |
| 07/20/2005 | EP1226164A4 Human metabotropic glutamate receptor |
| 07/20/2005 | EP1222301B1 Protein production system |
| 07/20/2005 | EP1210440B1 Taq dna polymerases having an amino acid substitution at e681 and homologs thereof exhibiting improved salt tolerance |
| 07/20/2005 | EP1198570B1 Monomeric protein of the tgf-beta family |
| 07/20/2005 | EP1176194B1 Method of cell cultivation |
| 07/20/2005 | EP1141712B1 Composite arrays utilizing microspheres |
| 07/20/2005 | EP1121137B1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 07/20/2005 | EP1058851B1 Devide and method for transferring magnetic particles |
| 07/20/2005 | EP1038022B1 Assessment of human papilloma virus-related disease |
| 07/20/2005 | EP1012336B1 Screening method for determining individuals at risk of developing diseases associated with different polymorphic forms of wildtype p53 |
| 07/20/2005 | EP1005538B1 Potassium channel proteins for use in gene therapy for alleviating erectile dysfunction |
| 07/20/2005 | EP0979281B1 A method for making multispecific antibodies having heteromultimeric and common components |
| 07/20/2005 | EP0977878B1 Dna sequences coding for subunit chld of plant magnesium chelatases for determining their action |
| 07/20/2005 | EP0972086A4 Expression cloning processes for the discovery, characterization and isolation of genes encoding polypeptides with a predetermined property |
| 07/20/2005 | EP0965637B1 Fas ANTIGEN DERIVATIVES |
| 07/20/2005 | EP0934407B1 Polycation-sensing receptor in aquatic species and methods of use thereof |
| 07/20/2005 | EP0929677B1 Recombinant method for preparing a complete malaria antigen gp190/msp1 |
| 07/20/2005 | EP0925362B1 Transgenic plants expressing cellulolytic enzymes |
| 07/20/2005 | EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 07/20/2005 | EP0904364B1 Electrode capture of nucleic acid |
| 07/20/2005 | EP0828851B1 Tripeptidylpeptidase inhibitors |
| 07/20/2005 | EP0789761B1 Human scf, a splice variant thereof, its pharmaceutical use |
| 07/20/2005 | EP0759075B1 Apoptosis regulating gene |
| 07/20/2005 | EP0721500B1 Insulin-secreting cell lines, methods of production and use |
| 07/20/2005 | EP0703983B9 Regulation of plant growth |
| 07/20/2005 | EP0703785B1 Methods for treating muscle diseases and disorders |
| 07/20/2005 | CN1643379A Luminescent, spherical, non-autofluorescent silica gel particles having variable emission intensities and frequencies |
| 07/20/2005 | CN1643378A Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| 07/20/2005 | CN1643164A Recombinant bovine immunodeficiency virus based gene transfer system |
| 07/20/2005 | CN1643162A Novel HMGA alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits |
| 07/20/2005 | CN1643157A Improved method for the production of vitamin B12 |
| 07/20/2005 | CN1643154A Process for preparing chiral aromatic alpha-hydroxy ketones using 2-hydroxy-3-oxoacid synthase |
| 07/20/2005 | CN1643153A Engineered baculoviruses and their use |
| 07/20/2005 | CN1643152A Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms |
| 07/20/2005 | CN1643151A Gene participating in acetic acid tolerance, acetic acid bacterium bred using the gene, and process for producing vinegar with the use of the acetic acid bacterium |
| 07/20/2005 | CN1643150A Gene participating in the synthesis of brassinosteroid |
| 07/20/2005 | CN1643149A Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
| 07/20/2005 | CN1643148A Mouse spermatogenesis genes, human male sterility-associated genes and diagnostic system using the same |
| 07/20/2005 | CN1643147A Methods and means for monitoring and modulating gene silencing |
| 07/20/2005 | CN1643146A Generation of multiple embryo maize |
| 07/20/2005 | CN1643145A Purification methods for oligonucleotides and their analogs |
| 07/20/2005 | CN1643144A Method of repressing flowering in a plant |
| 07/20/2005 | CN1643142A Method of identifying genes controlling diferentiation |
| 07/20/2005 | CN1643141A Saccharomyces cerevisiae yeast strain with improved phytase activity |
| 07/20/2005 | CN1643139A Bacteriophages |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |
| 07/20/2005 | CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 07/20/2005 | CN1643132A Container with at least one electrode |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642976A A mutated immunoglobulin-binding protein |
| 07/20/2005 | CN1642971A A nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/20/2005 | CN1642968A A human ribonucleotide reductase M2 subunit |
| 07/20/2005 | CN1642967A Clinical grade vectors based on natural microflora for use in delivering therapeutic compositions |
| 07/20/2005 | CN1642951A Heterocyclic tripeptides as hepatitis c inhibitors |
| 07/20/2005 | CN1642631A Apparatus for treatment of light-sensitive biopolymers |
| 07/20/2005 | CN1642579A Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1642560A Hyaluronic acid mediated adenoviral transduction |
| 07/20/2005 | CN1642432A Method of improving food fermentation procedures |
| 07/20/2005 | CN1642418A Effect of treatment with 4, 5-dihydroxy- 2-cyclopenten-1-ketone (DHCP) on gene expression and quorum-sensing in bacteria |
| 07/20/2005 | CN1641040A Method for configuring CDMA library and its special primer |
| 07/20/2005 | CN1641036A Humandrg2 recombinant adenovirus expresion vector configuration and use of anti-tumour recombinant adenovirus |
| 07/20/2005 | CN1641035A Plasmid of recombinant immunotoxin IP 10-DT 390 aimed at activating Th1 cell, and its preparing method and use |
| 07/20/2005 | CN1641034A Method for preparing tetanus toxin recombinant antigen and its use |
| 07/20/2005 | CN1641033A Novel marneffei penicillium TIM9 protein and its coding sequence |
| 07/20/2005 | CN1641032A Novel marneffei penicillium ERG25 Gene and its coding protein |
| 07/20/2005 | CN1641031A Novel marneffei penicillium TIM17 protein and its coding sequence |
| 07/20/2005 | CN1641030A Gene encoding cysteine protease and its promoter and method for producing male sterile rice |
| 07/20/2005 | CN1641029A Wheat disease-resistant gene Lr-L1 and its use |
| 07/20/2005 | CN1641028A Arabidopsis transcription factor, and its coding gene and use |
| 07/20/2005 | CN1641027A Wheat VER2 gene promotor |
| 07/20/2005 | CN1641026A Process for preparing engineered recombinant thymosin alpha |
| 07/20/2005 | CN1641025A Pagrosomus major antibacterial peptide gene, and recombinant yeast expression vector and its preparing method |
| 07/20/2005 | CN1641024A Anti EB virus resulted tumour polypeptide, and its use and preparing method |
| 07/20/2005 | CN1641023A Plasmid of recombinant immunotoxin Rantes-DT390 aimed at activating Th1 cell, and its preparing method and use |
| 07/20/2005 | CN1641022A Method for preparing transgene using rice calmodulin binding protein kinase gene and its use |
| 07/20/2005 | CN1641021A NDRG2 and NDRG4 protein and their use for diagnosing and suppressing tumour |
| 07/20/2005 | CN1641020A Basic alpha-diastase, and its coding gene and production method |
| 07/20/2005 | CN1641019A Cephalosporin C acylases |
| 07/20/2005 | CN1640891A Epinephelus anti-transgenosis protein and nucleotide sequence and use thereof |
| 07/20/2005 | CN1640890A Cell withering factor derivated from placents |
| 07/20/2005 | CN1640884A Foot and mouth disease virus infectious complementary deoxyribonucleic acid and its preparation method |
| 07/20/2005 | CN1211488C Modified plant viruses as vectors of heterologous peptides |
| 07/20/2005 | CN1211487C Mutants of streptococcal toxin A and methods of use |
| 07/20/2005 | CN1211486C A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| 07/20/2005 | CN1211485C Method for preparing recombined albumin |
| 07/20/2005 | CN1211484C Novel DNA fragment elevating gene expression dose |
| 07/20/2005 | CN1211483C Polypeptides having branching enzyme activity and nucleic acids encoding same |
| 07/20/2005 | CN1211402C Novel use of mouse leukocyte interleukin-17 receptor sample protein |
| 07/20/2005 | CN1211401C Human leukocyte interleukin-17 receptor sample protein, and coding gene and use thereof |
| 07/20/2005 | CN1211400C Process for preparing human blood platelet glucoprotein GPIb alpha and its special primer |
| 07/20/2005 | CN1211399C Method for producing L-leucine and related DNA and microorganism |
| 07/20/2005 | CN1211398C Computer based method for identifying conserved invariant peptide motifs |
| 07/20/2005 | CN1211360C Method for preparing methioylamine and methionine |